FIGS

Figs Inc., a healthcare apparel company, demonstrates strong momentum characteristics with a Zacks Momentum Style Score of B and a Zacks Rank #2 (Buy) rating. The stock has surged 16.72% over the past week and 150.21% over the past year, significantly outperforming the S&P 500. Recent earnings estimate revisions have been positive, with consensus estimates increasing from $0.32 to $0.36 in the past 60 days, supporting the bullish outlook.

FIGS, Inc. reported robust second-quarter 2026 results with active customers rising 13.2% to 3.1 million and revenue per customer hitting a record $229. Scrubwear sales grew 26.5% while non-scrubwear revenues jumped 40.3%, driven by product innovation and repeat purchases. The company raised its full-year revenue growth outlook to approximately 20%, marking its third consecutive quarter of growth above 25%.

On October 12, 2026, the Dow Jones rose 0.38% while the S&P 500 and Nasdaq declined as investors rotated into value sectors away from technology. Memory chip stocks and semiconductor names faced pressure amid valuation concerns, while Meta Platforms gained on its new AI model launch and Figs surged over 12%. Bank earnings and inflation data are expected this week.